UPC Analytics
DEEN
Übersicht · Eingereicht: 4. Dez. 2023

UPC_CFI_463/2023

METHOD AND PRODUCT FOR LOCALISED OR SPATIAL DETECTION OF NUCLEIC ACID IN A TISSUE SAMPLE

Einstweilige MaßnahmenEinstweilige MaßnahmenDusseldorf LDProvisional measuresCase Closed
ÜbersichtEntscheidungenBegründungZitateDokumenteZeitverlauf
Parteien

Kläger

  • 10x Genomics, Inc.
Vertreter: Tilman Müller-Stoy (Bardehle Pagenberg); Martin Drews (Bardehle Pagenberg); Axel Berger (Bardehle Pagenberg)

Beklagte

  • Curio Bioscience Inc.
Vertreter: Agathe Michel-De Cazotte; Cameron Marschall
Richter
  • Ronny Thomas
  • Berenice Thom
  • Andras Kupecz
  • Martin Schmidt
Patente
  • EP2697391
  • EP 2 697 391
CPC-Codes: C12Q1/6827, C12Q1/6841, C12Q1/6837, C12Q1/6853, G01N1/30, G16B30/00, C12Q1/6816, C12N15/11, G16B50/20, C12Q1/6844, C12Q1/6876, G16B50/30…

Sektor: Biotechnology

Ausgang
PI erteilt
Eingereicht: 4. Dez. 2023
Erste Entscheidung: 29. Jan. 2024
Letzte Entscheidung: 14. Feb. 2024
Sprache: English

The Düsseldorf Local Division granted a preliminary injunction against Curio Bioscience Inc. prohibiting it from offering, marketing, using, importing or storing arrays for spatially localised nucleic acid detection in Germany, France and Sweden, finding prima facie infringement of EP 2 697 391 B1 (owned by 10x Genomics). Both parties were ordered to pay each other interim costs of EUR 100,000. The injunction was conditional on 10x Genomics providing security of EUR 2,000,000. 10x Genomics' application for security for costs from the defendant was rejected.

Im UPC-Register öffnen